Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


Articles published in J Neurol Neurosurg Psychiatry

Retrieve available abstracts of 40 articles:
HTML format
Text format



Single Articles


    July 2017
  1. CILIA R, Asselta R, Cereda E, Benfante R, et al
    Opioid K receptor variant is associated with a delayed onset of dyskinesias in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Jul 19. pii: jnnp-2017-316235.
    PubMed     Text format    


    June 2017
  2. VAN DER KOLK NM, de Vries NM, Penko AL, van der Vlugt M, et al
    A remotely supervised home-based aerobic exercise programme is feasible for patients with Parkinson's disease: results of a small randomised feasibility trial.
    J Neurol Neurosurg Psychiatry. 2017 Jun 12. pii: jnnp-2017-315728.
    PubMed     Text format    


  3. AARSLAND D, Rajkumar AP, Hye A
    Novel evidence associates higher plasma alpha-synuclein levels and cognitive impairment in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Jun 12. pii: jnnp-2017-315821.
    PubMed     Text format    


  4. NISHIO Y, Yokoi K, Uchiyama M, Mamiya Y, et al
    Deconstructing psychosis and misperception symptoms in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Jun 9. pii: jnnp-2017-315741.
    PubMed     Text format     Abstract available


    May 2017
  5. AMARA AW, Chahine LM, Caspell-Garcia C, Long JD, et al
    Longitudinal assessment of excessive daytime sleepiness in early Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 May 29. pii: jnnp-2016-315023.
    PubMed     Text format     Abstract available


  6. LIN CH, Yang SY, Horng HE, Yang CC, et al
    Plasma alpha-synuclein predicts cognitive decline in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 May 26. pii: jnnp-2016-314857.
    PubMed     Text format     Abstract available


    April 2017
  7. FFYTCHE DH, Pereira JB, Ballard C, Chaudhuri KR, et al
    Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative.
    J Neurol Neurosurg Psychiatry. 2017;88:325-331.
    PubMed     Text format     Abstract available


  8. ANTONINI A, Barone P, Bonuccelli U, Annoni K, et al
    ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017;88:317-324.
    PubMed     Text format     Abstract available


  9. FIRBANK MJ, Yarnall AJ, Lawson RA, Duncan GW, et al
    Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study.
    J Neurol Neurosurg Psychiatry. 2017;88:310-316.
    PubMed     Text format     Abstract available


    March 2017
  10. LAWSON RA, Yarnall AJ, Duncan GW, Breen DP, et al
    Stability of mild cognitive impairment in newly diagnosed Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Mar 1. pii: jnnp-2016-315099.
    PubMed     Text format     Abstract available


  11. HO AL, Ali R, Connolly ID, Henderson JM, et al
    Awake versus asleep deep brain stimulation for Parkinson's disease: a critical comparison and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2017 Mar 1. pii: jnnp-2016-314500.
    PubMed     Text format     Abstract available


  12. NOYCE AJ, Schrag A, Masters JM, Bestwick JP, et al
    Subtle motor disturbances in PREDICT-PD participants.
    J Neurol Neurosurg Psychiatry. 2017;88:212-217.
    PubMed     Text format     Abstract available


    December 2016
  13. TEKRIWAL A, Kern DS, Tsai J, Ince NF, et al
    REM sleep behaviour disorder: prodromal and mechanistic insights for Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2016 Dec 13. pii: jnnp-2016-314471.
    PubMed     Text format     Abstract available


    November 2016
  14. FERRARI R, Wang Y, Vandrovcova J, Guelfi S, et al
    Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases.
    J Neurol Neurosurg Psychiatry. 2016 Nov 29. pii: jnnp-2016-314411.
    PubMed     Text format     Abstract available


  15. COLLETT J, Franssen M, Meaney A, Wade D, et al
    Phase II randomised controlled trial of a 6-month self-managed community exercise programme for people with Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2016 Nov 11. pii: jnnp-2016-314508.
    PubMed     Text format     Abstract available


    October 2016
  16. DE PABLO-FERNANDEZ E, Breen DP, Bouloux PM, Barker RA, et al
    Neuroendocrine abnormalities in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2016 Oct 31. pii: jnnp-2016-314601.
    PubMed     Text format     Abstract available


    September 2016
  17. SWALLOW DM, Lawton MA, Grosset KA, Malek N, et al
    Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts.
    J Neurol Neurosurg Psychiatry. 2016 Sep 26. pii: jnnp-2016-313642.
    PubMed     Text format     Abstract available


    August 2016
  18. LITTLE S, Tripoliti E, Beudel M, Pogosyan A, et al
    Adaptive deep brain stimulation for Parkinson's disease demonstrates reduced speech side effects compared to conventional stimulation in the acute setting.
    J Neurol Neurosurg Psychiatry. 2016 Aug 16. pii: jnnp-2016-313518.
    PubMed     Text format    


    July 2016
  19. KALBE E, Rehberg SP, Heber I, Kronenbuerger M, et al
    Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.
    J Neurol Neurosurg Psychiatry. 2016 Jul 8. pii: jnnp-2016-313838.
    PubMed     Text format     Abstract available


    June 2016
  20. MCMILLAN CT, Wolk DA
    Presence of cerebral amyloid modulates phenotype and pattern of neurodegeneration in early Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2016 Jun 9. pii: jnnp-2015-312690.
    PubMed     Text format     Abstract available


    April 2016
  21. KRAEMMER J, Smith K, Weintraub D, Guillemot V, et al
    Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2016 Apr 13. pii: jnnp-2015-312848.
    PubMed     Text format     Abstract available


    March 2016
  22. ERRO R, Schneider SA, Stamelou M, Quinn NP, et al
    What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies.
    J Neurol Neurosurg Psychiatry. 2016;87:319-23.
    PubMed     Text format     Abstract available


    February 2016
  23. XIAO B, Ng HH, Takahashi R, Tan EK, et al
    Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges.
    J Neurol Neurosurg Psychiatry. 2016 Feb 1. pii: jnnp-2015-312036.
    PubMed     Text format     Abstract available


    January 2016
  24. EVANS JR, Cummins G, Breen DP, Foltynie T, et al
    Comparative epidemiology of incident Parkinson's disease in Cambridgeshire, UK.
    J Neurol Neurosurg Psychiatry. 2016 Jan 22. pii: jnnp-2015-312581.
    PubMed     Text format    


  25. NOYCE AJ, Lees AJ, Schrag AE
    The prediagnostic phase of Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2016 Jan 11. pii: jnnp-2015-311890.
    PubMed     Text format     Abstract available


    December 2015
  26. MOISAN F, Kab S, Mohamed F, Canonico M, et al
    Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2015 Dec 23. pii: jnnp-2015-312283.
    PubMed     Text format     Abstract available


    November 2015
  27. SMITH KM, Xie SX, Weintraub D
    Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease.
    J Neurol Neurosurg Psychiatry. 2015 Nov 3. pii: jnnp-2015-311827.
    PubMed     Text format     Abstract available


    September 2015
  28. LITTLE S, Beudel M, Zrinzo L, Foltynie T, et al
    Bilateral adaptive deep brain stimulation is effective in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2015 Sep 30. pii: jnnp-2015-310972.
    PubMed     Text format     Abstract available


  29. YAMADA K, Shinojima N, Hamasaki T, Kuratsu JI, et al
    Subthalamic nucleus stimulation improves Parkinson's disease-associated camptocormia in parallel to its preoperative levodopa responsiveness.
    J Neurol Neurosurg Psychiatry. 2015 Sep 30. pii: jnnp-2015-310926.
    PubMed     Text format     Abstract available


  30. TADA S, Furuta M, Fukada K, Hirozawa D, et al
    Severe parkinsonism associated with anti-CRMP5 antibody-positive paraneoplastic neurological syndrome and abnormal signal intensity in the bilateral basal ganglia.
    J Neurol Neurosurg Psychiatry. 2015 Sep 15. pii: jnnp-2015-311569.
    PubMed     Text format    


  31. SAMMARTINO F, Krishna V, King NK, Bruno V, et al
    Sequence of electrode implantation and outcome of deep brain stimulation for Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2015 Sep 9. pii: jnnp-2015-311426.
    PubMed     Text format     Abstract available


  32. ADAMS-CARR KL, Bestwick JP, Shribman S, Lees A, et al
    Constipation preceding Parkinson's disease: a systematic review and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2015 Sep 7. pii: jnnp-2015-311680.
    PubMed     Text format     Abstract available


    August 2015
  33. DE CHAZERON I, Pereira B, Chereau-Boudet I, Durif F, et al
    Impact of localisation of deep brain stimulation electrodes on motor and neurobehavioural outcomes in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2015 Aug 21. pii: jnnp-2015-310953.
    PubMed     Text format     Abstract available


  34. FONG M, Ghahreman A, Masters L, Huynh W, et al
    Large intracranial meningioma masquerading as Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2015 Aug 4. pii: jnnp-2015-311531.
    PubMed     Text format    


    July 2015
  35. LING H, Kearney S, Yip HL, Silveira-Moriyama L, et al
    Parkinson's disease without nigral degeneration: a pathological correlate of scans without evidence of dopaminergic deficit (SWEDD)?
    J Neurol Neurosurg Psychiatry. 2015 Jul 24. pii: jnnp-2015-310756.
    PubMed     Text format     Abstract available


    June 2015
  36. FARRET MS, Cersosimo MG, Ramirez Gomez CC, Micheli F, et al
    Clinicoradiological comparisons between vascular parkinsonism and Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2015 Jun 10. pii: jnnp-2015-311155.
    PubMed     Text format    


    May 2015
  37. WATANABE H, Sobue G
    Filling in the missing puzzle piece between cardiac MIBG scintigraphy findings and Parkinson's disease pathology.
    J Neurol Neurosurg Psychiatry. 2015 May 22. pii: jnnp-2015-310862.
    PubMed     Text format    


  38. MUXI A
    The 'parkinsonian heart': a diagnostic and prognostic tool.
    J Neurol Neurosurg Psychiatry. 2015 May 18. pii: jnnp-2015-310785.
    PubMed     Text format    


  39. VRIEND C, Boedhoe PS, Rutten S, Berendse HW, et al
    A smaller amygdala is associated with anxiety in Parkinson's disease: a combined FreeSurfer-VBM study.
    J Neurol Neurosurg Psychiatry. 2015 May 18. pii: jnnp-2015-310383.
    PubMed     Text format     Abstract available


    April 2015
  40. SATZER D, Maurer EW, Lanctin D, Guan W, et al
    Anatomic correlates of deep brain stimulation electrode impedance.
    J Neurol Neurosurg Psychiatry. 2015;86:398-403.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: